Haughey Thomas's Form 4 filing
Ani Pharmaceuticals IncANIP · filed Jun 10, 2026
- Accession no.
- 0001272247-26-000004
- Filed
- Jun 10, 2026
- Trade date
- May 21-Jun 8, 2026
- Filing delay
- 20 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $161.8K. It was filed 20 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Haughey ThomasCIK 0001272247 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | AGrant or awardAcquired | +4,357 | $0.00 | $0 | 40,878 | Direct | |
| Jun 8, 2026 | Common Stock | SSaleDisposed | −2,000 | $80.88 | −$161,760 | 38,878 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.